This first volume chronicles the early stages of the outbreak and world-wide spread of SARS-Cov-2 (COVID-19) and delineates the role of several disciplines in therapeutic and control measures. Documenting the epidemiologic response from China, the clinical evaluation, pathology and intial therapeutics that were available during the first 6 months and onwards of the outbreak, this book records how the response to the pandemic was mounted and how various branches of science and research combined to rapidly expand our understanding of the disease.

What We Know About the Life-threatening Novel Human Coronavirus; Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2): Structure, Lifecycle, and Replication Machinery; Accumulated Epidemiological Lessons and China's COVID-19 Response; Clinical Presentation, Pathophysiology and Histopathology; Evaluation of the Disease, Sample Collection and Diagnostics; Therapeutic Options Initially Available for COVID-19 Patients and Initial Clinical Trials; Clinical Epidemiology of Coronavirus Disease 2019: Infectivity, Clinical Spectrum and Presentation, and Population Distribution; SARS-CoV-2 Genomics and Host Cellular Susceptibility Factors of COVID-19; Infection and Pathogenesis of SARS-CoV-2:an Immunological Perspective; Neurological Manifestations in COVID-19; COVID-19 and Coagulopathy; COVID-19 Endocrinopathies: Implications for Care; Potential Risks of COVID-19 in Reproductive Health; Clinical Autopsy in COVID-19; COVID-19 Pharmacotherapy - Present and Future; Knowledge from Human Relevant Cell, Tissue and Mathematics-based Methods as Key Tools for Understanding COVID-19 Dynamics, Kinetics, Symptoms, Risk Factors and Non-conventional Treatments;